26 results on '"Chao R"'
Search Results
2. P90.03 A Phase 2 Trial of MRTX849 in Combination with Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
3. P2.01-14 Phase 3 Trial of Sitravatinib Plus Nivolumab vs Docetaxel for Treatment of NSCLC After Platinum-Based Chemoimmunotherapy
4. Sitravatinib demonstrates activity in patients with novel genetic alterations that inactivate CBL
5. P3.01-048 CBL Mutations as Potential Mediators of EGFR TKI Resistance Effectively Treated with Sitravatinib
6. Regional anesthesia as an alternative to conscious sedation for perioperative pain control for percutaneous gastrostomy tube placement
7. Amethyst NSCLC trial: Phase 2, parallel-arm study of receptor tyrosine kinase (RTK) inhibitor, MGCD265 in patients with advanced or metastatic non-small cell lung cancer (NSCLC) with activating genetic alterations in mesenchymal-epithelial transition factor (MET)
8. 370 A first-in-human phase 1/1b study of receptor tyrosine kinase (RTK) inhibitor, MGCD, in patients with advanced solid tumors
9. Updated Overall Survival (OS) Analysis from a Phase III Study of Sunitinib vs Placebo in Patients (PTS) with Advanced, Unresectable Pancreatic Neuroendocrine Tumor (NET)
10. 9155 Sunitinib combined with pemetrexed and cisplatin in patients with advanced solid malignancies: phase I dose escalation study
11. 9143 Health-related quality of life (HRQOL) with sunitinib (SU) as maintenance therapy following carboplatin (C) and paclitaxel (P) treatment for locally advanced or metastatic non-small cell lung cancer (NSCLC)
12. 9153 Safety and efficacy of sunitinib in patients with non-small cell lung cancer and irradiated brain metastases
13. 6548 POSTER Phase II study of sunitinib malate (SU) as consolidation therapy in patients (pts) with locally-advanced or metastatic non-small cell lung cancer (NSCLC)
14. 6511 ORAL Phase II study of erlotinib (E) with or without sunitinib (SU) in the treatment of metastatic non-small cell lung cancer (NSCLC)
15. 3542 POSTER Preliminary results from a phase II study of sunitinib as second-line treatment for advanced gastric cancer
16. 3065 POSTER Safety and efficacy of sunitinib and FOLFIRI in combination in treatment-naive metastatic colorectal cancer (mCRC): a phase I study
17. 716 POSTER Sunitinib combined with modified (m) FOLFOX6 chemotherapy in patients with advanced solid tumors: a phase I study
18. 711 POSTER Sunitinib (SU) plus docetaxel (D) in patients (pts) with advanced solid tumors: a phase I dose-escalation and pharmacokinetic (PK) study
19. 6607 POSTER Preliminary findings of a phase I dose-escalation study of sunitinib in combination with gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC)
20. 714 POSTER Phase I tolerability/safety of sunitinib in combination with capecitabine in patients (pts) with advanced solid tumors
21. Phase II Study of Continuous Daily Sunitinib Dosing in Patients with Previously Treated Advanced Non–Small-Cell Lung Cancer (NSCLC)
22. Shore platform abrasion in a para-periglacial environment, Galicia, northwestern Spain
23. Application of a CFD Code (FLUENT) to Formulate Models of Catalytic Gas Phase Reactions in Porous Catalyst Pellets
24. Environmental change and social dynamics in the second–third millennium BC in NW Iberia
25. Retinoblastoma protein dephosphorylation induced by D-erythro-sphingosine.
26. Multiple interacting sites regulate astrocyte-specific transcription of the human gene for glial fibrillary acidic protein.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.